key: cord-0974370-8dc8o053
authors: Wallace, Zachary S; Bhana, Suleman; Hausmann, Jonathan S; Robinson, Philip C; Sufka, Paul; Sirotich, Emily; Yazdany, Jinoos; Grainger, Rebecca
title: The Rheumatology Community responds to the COVID-19 pandemic: the establishment of the COVID-19 global rheumatology alliance
date: 2020-05-06
journal: Rheumatology (Oxford)
DOI: 10.1093/rheumatology/keaa191
sha: 25a8153e0176954be0a601ed40b4c7810e8857a9
doc_id: 974370
cord_uid: 8dc8o053

nan

an interest in joining this international effort. Importantly, representatives from different types of practice settings (community and academic), research fields (basic science, translational and clinical research) and patient groups have brought a variety of perspectives to the collaboration. Within the first week, over 250 members joined and participated in the Slack channel, generating over 4000 messages, and almost 100 documents. Over 100 organizations also pledged their support for the effort. Social media has enabled the rheumatology community to exchange ideas in real time, rapidly mobilizing efforts to address the knowledge gaps for people with rheumatic disease in the COVID-19 pandemic.

From these beginnings, the COVID-19 Global Rheumatology Alliance (GRA) took shape as a grassroots organization with activities and priorities identified and led by its members. The collaborators quickly identified several potential avenues of work and investigation, including: (i) development of a physician-reported registry of people with rheumatic disease and COVID-19 infections; (ii) collaborating with patient-facing organizations to develop standardized patient-reported surveys to collect data about the patient experience during the COVID-19 pandemic; (iii) working with insurance payers to query large administrative/claims databases for COVID-19 infections in relevant populations; (iv) addressing knowledge gaps relevant to people with rheumatic disease via evidence synthesis; and (v) the dissemination of resources to patients and health professionals.

With participation growing exponentially over a few short days, a steering committee was formed. The GRA Steering Committee was assembled with representatives from each of the workgroups (Fig. 1) to champion those efforts, as well as to serve as a leadership body that could establish policies (e.g. authorship, conflicts of interest), develop a website (https://rheum-covid.org), organize volunteers, and serve as liaisons to collaborating groups, which include a growing list of organizations such as the American College of Rheumatology, the European League Against Rheumatology, patient groups and organizations (e.g. universities and industry) offering to provide organizational, administrative or financial support for the effort. The fundamental principle guiding GRA Steering Committee decision-making is to include all interested parties-patients, rheumatology health professionals and patient groups-in a process that is In less than two weeks, the COVID-19 Global Rheumatology Alliance has evolved from a conversation on Twitter into an international collaboration of rheumatology providers and other related specialists, researchers and people with rheumatic disease. The global nature of the COVID-19 pandemic necessitates that the response is supported by scientific contributions from providers, researchers and patients from all nations. The products of these collaborations and contributions will answer fundamental questions relevant to our patients and inform the care of people with rheumatic disease during the evolving COVID-19 pandemic. The rapid mobilization of efforts by leveraging online communications has enabled international co-operation at a time when our usual way of interacting and collaborating has been severely curtailed. These are uncertain times and it is unclear what we might face. The COVID-19 Global Rheumatology Alliance is one way that the rheumatology community is uniting in efforts to gain and disseminate knowledge that might help us in supporting our patients and communities through this unprecedented pandemic.

Covid-19-navigating the uncharted

An Interactive web-based dashboard to track COVID-19 in real time

In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

COVID-19: consider cytokine storm syndromes and immunosuppression

Trump's embrace of unproven drugs to treat coronavirus defies science

Coronavirus Disease (COVID-19)

Totally smart thing to do-Are we doing this in RHEUM? I am unaware @CCalabreseDO @AWIRGROUP @RheumJC @DrBhana @psufka @jasonsknight @DanielHSolomon @BharatKumarMD @RheumNow @ACRheum @eular_org @philipcrobinson @ThrouNeedlesEye @MdWarrington @DrDavidKarp @RheumatologyUK